data_1mbg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mbg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.5 mm -67.34 149.04 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -78.29 -162.57 0.36 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.36 171.0 6.91 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.61 154.64 24.51 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.903 2.402 . . . . 0.0 111.53 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -59.07 143.54 48.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.406 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 p -113.09 159.56 19.08 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -58.65 -39.13 79.72 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -66.48 -46.11 77.42 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -56.94 -47.35 80.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.24 -39.46 94.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.922 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -53.68 -43.34 68.81 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -59.64 -51.97 67.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.13 -47.28 84.16 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 77.7 mt -53.83 -54.02 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.52 -52.88 63.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.708 -0.223 . . . . 0.0 110.475 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.1 mt -57.94 -40.8 81.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.387 0.275 . . . . 0.0 110.955 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 t -66.68 -34.6 71.11 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.515 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -73.71 -30.11 62.66 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -77.08 -65.44 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.874 0.47 . . . . 0.0 110.664 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -80.58 -35.49 34.15 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.302 0.241 . . . . 0.0 111.06 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.28 173.18 19.12 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.19 168.58 3.54 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.677 2.251 . . . . 0.0 110.666 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.4 mttm 66.5 -157.25 0.25 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtm-85 52.86 45.15 29.34 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -66.75 -21.88 66.06 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.709 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.8 m -65.23 -40.28 93.86 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.8 -47.16 57.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.4 mt -60.32 -44.01 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.76 81.52 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.417 0.287 . . . . 0.0 110.846 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -58.95 -26.73 64.67 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -90.27 -40.97 11.82 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.81 74.04 6.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -71.08 78.47 0.67 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.66 -30.66 0.11 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -125.59 130.09 50.97 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.2 pt -74.56 172.6 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -52.69 -38.65 53.3 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -59.16 -51.58 69.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 117.103 0.452 . . . . 0.0 110.253 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -65.48 -42.08 92.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.881 -0.145 . . . . 0.0 110.684 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 84.7 m -59.64 -43.14 93.97 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -63.68 -48.81 75.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.71 -57.42 13.07 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -42.49 -42.51 3.32 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.176 0.297 . . . . 0.0 110.229 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 21.4 t-105 -78.45 -47.47 17.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -85.24 40.75 0.84 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.314 0.245 . . . . 0.0 111.051 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -141.94 -80.41 0.23 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 -44.09 3.58 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.606 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.15 70.06 3.5 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -131.18 62.64 66.49 Favored Pre-proline 0 CA--C 1.535 0.368 0 O-C-N 121.954 -0.466 . . . . 0.0 111.135 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -63.27 -47.86 7.19 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.222 1.948 . . . . 0.0 109.293 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -80.82 55.95 2.56 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 O-C-N 122.242 -0.286 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.5 mm -67.34 149.04 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -78.29 -162.57 0.36 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.36 171.0 6.91 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.61 154.64 24.51 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.903 2.402 . . . . 0.0 111.53 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -59.07 143.54 48.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.406 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 p -113.09 159.56 19.08 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -58.65 -39.13 79.72 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -66.48 -46.11 77.42 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -56.94 -47.35 80.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.24 -39.46 94.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.922 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -53.68 -43.34 68.81 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -59.64 -51.97 67.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.13 -47.28 84.16 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 77.7 mt -53.83 -54.02 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.52 -52.88 63.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.708 -0.223 . . . . 0.0 110.475 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.1 mt -57.94 -40.8 81.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.387 0.275 . . . . 0.0 110.955 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 t -66.68 -34.6 71.11 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.515 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -73.71 -30.11 62.66 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -77.08 -65.44 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.874 0.47 . . . . 0.0 110.664 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -80.58 -35.49 34.15 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.302 0.241 . . . . 0.0 111.06 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.28 173.18 19.12 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.19 168.58 3.54 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.677 2.251 . . . . 0.0 110.666 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.4 mttm 66.5 -157.25 0.25 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtm-85 52.86 45.15 29.34 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -66.75 -21.88 66.06 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.709 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.8 m -65.23 -40.28 93.86 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.8 -47.16 57.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.4 mt -60.32 -44.01 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.76 81.52 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.417 0.287 . . . . 0.0 110.846 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -58.95 -26.73 64.67 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -90.27 -40.97 11.82 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.81 74.04 6.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -71.08 78.47 0.67 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.66 -30.66 0.11 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -125.59 130.09 50.97 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.2 pt -74.56 172.6 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -52.69 -38.65 53.3 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -59.16 -51.58 69.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 117.103 0.452 . . . . 0.0 110.253 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -65.48 -42.08 92.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.881 -0.145 . . . . 0.0 110.684 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 84.7 m -59.64 -43.14 93.97 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -63.68 -48.81 75.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.71 -57.42 13.07 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -42.49 -42.51 3.32 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.176 0.297 . . . . 0.0 110.229 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.401 ' CZ3' HD12 ' A' ' 138' ' ' LEU . 21.4 t-105 -78.45 -47.47 17.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -85.24 40.75 0.84 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.314 0.245 . . . . 0.0 111.051 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -141.94 -80.41 0.23 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 -44.09 3.58 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.606 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.401 HD12 ' CZ3' ' A' ' 134' ' ' TRP . 0.1 OUTLIER -77.15 70.06 3.5 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -131.18 62.64 66.49 Favored Pre-proline 0 CA--C 1.535 0.368 0 O-C-N 121.954 -0.466 . . . . 0.0 111.135 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -63.27 -47.86 7.19 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.222 1.948 . . . . 0.0 109.293 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -80.82 55.95 2.56 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 O-C-N 122.242 -0.286 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 tp . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 27.5 mm -67.34 149.04 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -78.29 -162.57 0.36 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.36 171.0 6.91 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.61 154.64 24.51 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.903 2.402 . . . . 0.0 111.53 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -59.07 143.54 48.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.406 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 p -113.09 159.56 19.08 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -58.65 -39.13 79.72 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -66.48 -46.11 77.42 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -56.94 -47.35 80.85 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.24 -39.46 94.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.922 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -53.68 -43.34 68.81 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -59.64 -51.97 67.52 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.3 t -57.13 -47.28 84.16 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 77.7 mt -53.83 -54.02 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.52 -52.88 63.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.708 -0.223 . . . . 0.0 110.475 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.1 mt -57.94 -40.8 81.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.387 0.275 . . . . 0.0 110.955 -177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.7 t -66.68 -34.6 71.11 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.515 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -73.71 -30.11 62.66 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -77.08 -65.44 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.874 0.47 . . . . 0.0 110.664 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -80.58 -35.49 34.15 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.302 0.241 . . . . 0.0 111.06 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 112.28 173.18 19.12 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.19 168.58 3.54 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.677 2.251 . . . . 0.0 110.666 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.4 mttm 66.5 -157.25 0.25 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtm-85 52.86 45.15 29.34 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -66.75 -21.88 66.06 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.709 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.8 m -65.23 -40.28 93.86 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.8 -47.16 57.91 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.4 mt -60.32 -44.01 94.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.76 81.52 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.417 0.287 . . . . 0.0 110.846 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -58.95 -26.73 64.67 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -90.27 -40.97 11.82 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.81 74.04 6.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -71.08 78.47 0.67 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.66 -30.66 0.11 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -125.59 130.09 50.97 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.2 pt -74.56 172.6 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -52.69 -38.65 53.3 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -59.16 -51.58 69.39 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 117.103 0.452 . . . . 0.0 110.253 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -65.48 -42.08 92.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.881 -0.145 . . . . 0.0 110.684 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 84.7 m -59.64 -43.14 93.97 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -63.68 -48.81 75.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.71 -57.42 13.07 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -42.49 -42.51 3.32 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.176 0.297 . . . . 0.0 110.229 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.401 ' CZ3' HD12 ' A' ' 138' ' ' LEU . 21.4 t-105 -78.45 -47.47 17.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -85.24 40.75 0.84 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.314 0.245 . . . . 0.0 111.051 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -141.94 -80.41 0.23 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.45 -44.09 3.58 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.606 -177.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.401 HD12 ' CZ3' ' A' ' 134' ' ' TRP . 0.1 OUTLIER -77.15 70.06 3.5 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -177.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -131.18 62.64 66.49 Favored Pre-proline 0 CA--C 1.535 0.368 0 O-C-N 121.954 -0.466 . . . . 0.0 111.135 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -63.27 -47.86 7.19 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 122.222 1.948 . . . . 0.0 109.293 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -80.82 55.95 2.56 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 O-C-N 122.242 -0.286 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_